Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Guggenheim Maintains Buy on Aptiv, Lowers Price Target to $92

Author: Benzinga Newsdesk | April 17, 2024 01:01pm
Guggenheim analyst Ronald Jewsikow maintains Aptiv (NYSE:APTV) with a Buy and lowers the price target from $103 to $92.

Posted In: APTV

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist